Exact Mass: 296.1525
Exact Mass Matches: 296.1525
Found 43 metabolites which its exact mass value is equals to given mass value 296.1525,
within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error
4.0E-5 dalton.
6-allyl-8b-Carboxy-ergoline
(2S,7S)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxylic acid
6-allyl-8b-Carboxy-ergoline is a metabolite of cabergoline. Cabergoline (brand names Dostinex and Cabaser), an ergot derivative, is a potent dopamine receptor agonist on D2 receptors. In vitro, rat studies show cabergoline has a direct inhibitory effect on pituitary lactotroph cells. It is frequently used as a first-line agent in the management of prolactinomas due to higher affinity for D2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine. (Wikipedia)
8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol
8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol
(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A
(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A
8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin
8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin
3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline
3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline
(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE
(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE
Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate
Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate
4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine
4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine
[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol
[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol
1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea
1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea
(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone
(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone
1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole
1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole
(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one
(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one
(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one
(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one
SN40
SN40
SN40 is a potent amino acid transport (AAT) inhibitor with Kis of 7.29 μM, 2.42 μM, 2.94 μM, 5.55 μM, 24.43 μM and 5.55 μM for rat ASCT2, human ASCT2, EAAT1, EAAT2, EAAC1 and EAAT5, respectively. SN40 can be used for researching anticancer[1].
(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one
(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one
(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
(1r,13s,16r)-16-hydroxy-5,14-diazapentacyclo[12.3.3.0¹,¹³.0⁴,¹².0⁶,¹¹]icosa-4(12),6,8,10-tetraen-15-one
(1r,13s,16r)-16-hydroxy-5,14-diazapentacyclo[12.3.3.0¹,¹³.0⁴,¹².0⁶,¹¹]icosa-4(12),6,8,10-tetraen-15-one
8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
(3s,6s)-13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
(3s,6s)-13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
(5as,13r)-8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
(5as,13r)-8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
n-(4-{[hydroxy(phenyl)methylidene]amino}butyl)benzenecarboximidic acid
n-(4-{[hydroxy(phenyl)methylidene]amino}butyl)benzenecarboximidic acid
4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
